추가 설명:
Pasireotide (CAS 396091-73-9, molecular formula C58H66N10O9, molecular weight 1047.21) is a cyclic peptide supplied at ≥98.0% purity. Marketed by Novartis as Signifor (SOM230), it is an orphan-designated somatostatin analog approved in the US and Europe for Cushing's disease in patients who are ineligible for or have failed surgery, distinguished by roughly 40-fold greater affinity for somatostatin receptor 5 than other analogs in its class.
평가 & 댓글 남기기